Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines

Breast Cancer Research and Treatment

Volumn 125, Issue 1, 2011, Pages 35-42

  Fernández Cuesta, Lynnette ^a   Anaganti, Suresh ^a   Hainaut, Pierre ^a   Olivier, Magali ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Apoptosis; Breast; Doxorubicin; Estradiol; Estrogen receptor; P53

Indexed keywords

DNA; DOXORUBICIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TREATMENT OUTCOME; WILD TYPE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MICE; MUTATION; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78650306296     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0819-x     Document Type: Article

References (34)

1. AJ Levine J Momand CA Finlay 1991 The p53 tumour suppressor gene Nature 351 453 456 1:CAS:528:DyaK3MXksVaku7g%3D 10.1038/351453a0 2046748
2. P Hainaut M Hollstein 2000 p53 and human cancer: the first ten thousand mutations Adv Cancer Res 77 81 137 1:CAS:528:DC%2BD3cXltl2ktQ%3D%3D 10.1016/S0065-230X(08)60785-X 10549356
3. Olivier M, Hainaut P, Borresen-Dale A (2005) Prognostic and predictive value of TP53 mutations in human cancer. In: Hainaut P, Wiman K (eds) 25 years of p53 research. Springer, pp 321-338
4. N Heldring A Pike S Andersson J Matthews G Cheng J Hartman M Tujague A Strom E Treuter M Warner JA Gustafsson 2007 Estrogen receptors: how do they signal and what are their targets Physiol Rev 87 905 931 1:CAS:528: DC%2BD2sXptFGls7k%3D 10.1152/physrev.00026.2006 17615392 (Pubitemid 47084672)
5. BJ Cheskis JG Greger S Nagpal LP Freedman 2007 Signaling by estrogens J Cell Physiol 213 610 617 1:CAS:528:DC%2BD2sXht12jtbfE 10.1002/jcp.21253 17886255 (Pubitemid 350058252)
6. RJ Santen P Fan Z Zhang Y Bao RX Song W Yue 2009 Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells Steroids 74 586 594 1:CAS:528: DC%2BD1MXksVCksbc%3D 10.1016/j.steroids.2008.11.020 19138696
7. V Duong N Boulle S Daujat J Chauvet S Bonnet H Neel V Cavailles 2007 Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents Cancer Res 67 5513 5521 1:CAS:528: DC%2BD2sXmtVaitb8%3D 10.1158/0008-5472.CAN-07-0967 17545634 (Pubitemid 46997293)
8. G Liu JA Schwartz SC Brooks 2000 Estrogen receptor protects p53 from deactivation by human double minute-2 Cancer Res 60 1810 1814 1:CAS:528:DC%2BD3cXisVyntbs%3D 10766163
9. C Hurd S Dinda N Khattree VK Moudgil 1999 Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells Oncogene 18 1067 1072 1:CAS:528: DyaK1MXhsVyiuro%3D 10.1038/sj.onc.1202398 10023683 (Pubitemid 29086284)
10. VK Moudgil S Dinda N Khattree S Jhanwar P Alban C Hurd 2001 Hormonal regulation of tumor suppressor proteins in breast cancer cells J Steroid Biochem Mol Biol 76 105 117 1:CAS:528:DC%2BD3MXks1altr0%3D 10.1016/S0960-0760(00)00151- 5 11384868 (Pubitemid 32510672)
11. SH Shirley JE Rundhaug J Tian N Cullinan-Ammann I Lambertz CJ Conti R Fuchs-Young 2009 Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells Cancer Res 69 3405 3414 1:CAS:528: DC%2BD1MXksV2hsbg%3D 10.1158/0008-5472.CAN-08-3628 19351845
12. SV Angeloni MB Martin P Garcia-Morales MD Castro-Galache JA Ferragut M Saceda 2004 Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells J Endocrinol 180 497 504 1:CAS:528: DC%2BD2cXivVyktr0%3D 10.1677/joe.0.1800497 15012604 (Pubitemid 38443401)
13. G Liu JA Schwartz SC Brooks 1999 p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE Biochem Biophys Res Commun 264 359 364 1:CAS:528:DyaK1MXms12qs7c%3D 10.1006/bbrc.1999.1525 10529369 (Pubitemid 29516092)
14. BD Jeffy JK Hockings MQ Kemp SS Morgan JA Hager J Beliakoff LJ Whitesell GT Bowden DF Romagnolo 2005 An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription Neoplasia 7 873 882 1:CAS:528:DC%2BD2MXhtlClurfK 10.1593/neo.05256 16229810
15. W Jin Y Chen GH Di P Miron YF Hou H Gao ZM Shao 2008 Estrogen Receptor (ER) beta or p53 attenuates ER{alpha}-mediated transcriptional activation on the BRCA2 promoter J Biol Chem 283 29671 29680 1:CAS:528:DC%2BD1cXht1ynt7vM 10.1074/jbc.M802785200 18765668
16. W Liu SD Konduri S Bansal BK Nayak SA Rajasekaran SM Karuppayil AK Rajasekaran GM Das 2006 Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function J Biol Chem 281 9837 9840 1:CAS:528:DC%2BD28Xjt1Kntrc%3D 10.1074/jbc.C600001200 16469747 (Pubitemid 43864514)
17. SA Lewandowski J Thiery A Jalil G Leclercq C Szczylik S Chouaib 2005 Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity Oncogene 24 4789 4798 1:CAS:528:DC%2BD2MXmtVymtb8%3D 10.1038/sj.onc.1208595 15870704 (Pubitemid 41076296)
18. AM Molinari P Bontempo EM Schiavone V Tortora MA Verdicchio M Napolitano E Nola B Moncharmont N Medici V Nigro I Armetta C Abbondanza GA Puca 2000 Estradiol induces functional inactivation of p53 by intracellular redistribution Cancer Res 60 2594 2597 1:CAS:528:DC%2BD3cXjsF2gt7w%3D 10825127
19. D Menendez A Inga J Snipe O Krysiak G Schonfelder MA Resnick 2007 A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1 Mol Cell Biol 27 2590 2600 1:CAS:528:DC%2BD2sXjs1ajsLc%3D 10.1128/MCB.01742-06 17242190 (Pubitemid 46581350)
20. SW Lowe 1995 Cancer therapy and p53 Curr Opin Oncol 7 547 553 1:CAS:528:DyaK28XisFylsrg%3D 10.1097/00001622-199511000-00013 8547404
21. M Olivier A Langerod P Carrieri J Bergh S Klaar J Eyfjord C Theillet C Rodriguez R Lidereau I Bieche J Varley Y Bignon N Uhrhammer R Winqvist A Jukkola-Vuorinen D Niederacher S Kato C Ishioka P Hainaut AL Borresen-Dale 2006 The clinical value of somatic TP53 gene mutations in 1, 794 patients with breast cancer Clin Cancer Res 12 1157 1167 1:CAS:528:DC%2BD28XhsFalt7Y%3D 10.1158/1078-0432.CCR-05-1029 16489069 (Pubitemid 43342504)
22. E Shaulian A Zauberman D Ginsberg M Oren 1992 Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding Mol Cell Biol 12 5581 5592 1:CAS:528: DyaK3sXnvVagtw%3D%3D 1448088
23. C Salvat C Aquaviva I Jariel-Encontre P Ferrara M Pariat AM Steff S Carillo M Piechaczyk 1999 Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep 26 45 51 1:CAS:528:DyaK1MXjsVyltr0%3D 10.1023/A:1006960021281 10363646
24. Z Nawaz DM Lonard AP Dennis CL Smith BW O'Malley 1999 Proteasome-dependent degradation of the human estrogen receptor Proc Natl Acad Sci USA 96 1858 1862 1:CAS:528:DyaK1MXhvVSrtbY%3D 10.1073/pnas.96.5.1858 10051559 (Pubitemid 29117832)
25. AL Wijayaratne DP McDonnell 2001 The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators J Biol Chem 276 35684 35692 1:CAS:528:DC%2BD3MXntFahsbw%3D 10.1074/jbc.M101097200 11473106
26. BP Zhou Y Liao W Xia Y Zou B Spohn MC Hung 2001 HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation Nat Cell Biol 3 973 982 1:CAS:528:DC%2BD3MXosVeqsLo%3D 10.1038/ncb1101-973 11715018 (Pubitemid 34428742)
27. MH Kubbutat SN Jones KH Vousden 1997 Regulation of p53 stability by Mdm2 Nature 387 299 303 1:CAS:528:DyaK2sXjtlSgtLc%3D 10.1038/387299a0 9153396 (Pubitemid 27220767)
28. R Schiff S Massarweh J Shou CK Osborne 2003 Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response Clin Cancer Res 9 447S 454S 1:CAS:528:DC%2BD3sXnt1yjsw%3D%3D 12538499 (Pubitemid 36105786)
29. KA Becker S Lu ES Dickinson KA Dunphy L Mathews SS Schneider DJ Jerry 2005 Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways Oncogene 24 6345 6353 1:CAS:528:DC%2BD2MXhtVelsbbO 15940247
30. KA Dunphy AC Blackburn H Yan LR O'Connell DJ Jerry 2008 Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53 ± mice Breast Cancer Res 10 R43 10.1186/bcr2094 18471300
31. C Guillot N Falette S Courtois T Voeltzel E Garcia M Ozturk A Puisieux 1996 Alteration of p53 damage response by tamoxifen treatment Clin Cancer Res 2 1439 1444 1:CAS:528:DyaK28XmtFSrtrg%3D 9816318
32. AS Adhikari T Iwakuma 2009 Mutant p53 gain of oncogenic function: in vivo evidence, mechanism of action and its clinical implications Fukuoka Igaku Zasshi 100 217 228 1:CAS:528:DC%2BD1MXpsFSgur8%3D 19670804
33. R Brosh V Rotter 2009 When mutants gain new powers: news from the mutant p53 field Nat Rev Cancer 9 701 713 1:CAS:528:DC%2BD1MXhtVWhsb7J 19693097
34. T Terzian YA Suh T Iwakuma SM Post M Neumann GA Lang CS Van Pelt G Lozano 2008 The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss Genes Dev 22 1337 1344 1:CAS:528:DC%2BD1cXmsVWmtr4%3D 10.1101/gad.1662908 18483220 (Pubitemid 351717524)